Global InfertilityDrugs Market, By Drug Type (Clomiphene citrate, Sex hormones,Gonadotropins, Bromocriptine, Cabergoline, Imipramine, Letrozole, andMetformin), By Route of Administration (Oral, Intravenous, Subcutaneous, andIntramuscular), By Gender (Male and Female), By Distribution Channel (HospitalPharmacies, Retail Pharmacies and Online Pharmacies), and By Region (NorthAmerica, Latin America, Europe, Asia Pacific, Middle East, and Africa) wasvalued at US$ 3.8 billion in 2017, and is projected to exhibit a CAGR of 5.8%over the forecast period (2019 - 2026).
The infertility drugs market sizeis expanding, owing to increasing research studies for development of breakthroughdrugs for the treatment of infertility. According to a research conducted inPrinceton University in 2018, researchers have identified a key protein in old,poor-quality Caenorhabditis elegans (microscopic worm) eggs, which controls theaging of gametes. Researchers successfully blocked this protein during thefertile period of the worm (equivalent to woman’s fertility in thirties), andextended egg viability beyond the normal span. If these protein could beremoved from human genes, that could represent a 3 to 6 year extension offemale fertility. Increasing awareness about reproductive health in thepopulation is also highly contributing to the infertility drugs market growth.For instance, RESOLVE - The National Infertility Association organizes NationalInfertility Awareness Week (NIAW) every year in the last week of April since2010.
* The sample copy includes: Report Summary, Table ofContents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/2665
The goal of the week is to raiseawareness about infertility in maximum population, to encourage advocacy forinsurance in infertility drugs, and help couples with infertility cope withtheir disease. Browse 17 Market Data Tables and 12 Figures spread through 145Pages and in-depth TOC on " Global Infertility Drugs Market, By Drug Type(Clomiphene citrate, Sex hormones, Gonadotropins, Bromocriptine, Cabergoline,Imipramine, Letrozole, and Metformin), By Route of Administration (Oral,Intravenous, Subcutaneous, and Intramuscular), By Gender (Male and Female), ByDistribution Channel (Hospital Pharmacies, Retail Pharmacies and OnlinePharmacies) and By Region (North America, Latin America, Europe, Asia Pacific,Middle East, and Africa) - Global Forecast to 2026"
Furthermore, variousorganizations are focused on launching new programs to help infertile couples.For instance, in 2014, EMD Serono a subsidiary of Merck KGaA, Germany launchedits Compassionate Corps Program, a patient assistance program to provide fertilitymedications for eligible U.S. veterans who were infertile due to aservice-related injury. The company provides selected IVF stimulationmedications at no charge for up to two IVF cycles per year. Moreover, MerckKGaA partnered with Genea Biomedx in May 2015, securing global rights toGenea's portfolio of fertility products.
Browse ResearchReport: https://www.coherentmarketinsights.com/market-insight/infertility-drugs-market-2665
Key Takeaways of the InfertilityDrugs Market:
The global infertility drugsmarket is expected to expand at a CAGR of 5.8% during the forecast period(2019–2026), owing to increasing research & development and new infertilitydrug launches by companies.
Among the drug type, theClomiphene citrate segment is expected to hold major revenue share in 2026, asit is the most effective drug to treat infertility. According to a study publishedin National Centre for Biotechnology Information (NCBI) in 2012, a comparativestudy on effectiveness of clomiphene citrate and tamoxifen in ovulationinduction in infertile women showed that women treated with Clomiphene citrateshowed 64% increase in pregnancy rate than the women treated with tamoxifen,which showed only 40% increase in pregnancy rate.
Major players operating in theglobal infertility drugs market include Merck & Co., FerringPharmaceuticals, LIVZON Pharmaceutical Group Inc., AbbottLaboratories, BayerAG, and Zydus Pharmaceuticals.
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/2665
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related to emergingmarket trends, technologies, and potential absolute dollar opportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
